William Alazawi

Professor William Alazawi is a leading hepatologist at Queen Mary University of London, affiliated with the Blizard Institute's Centre for Immunobiology. His research focuses on Non-Alcoholic Fatty Liver Disease (NAFLD) and its progressive form, Non-Alcoholic Steatohepatitis (NASH), integrating molecular immunology, metabolic systems biology, and epidemiology.

• Academic rank: Professor of Hepatology
• Key roles: Director of Research at Blizard Institute, Co-Lead for NIHR Integrated Academic Training Programme, Chair of BASL Special Interest Group for NAFLD

Research Highlights: His group employs single-cell techniques to study immune-metabolic interactions in NASH, investigates multiorgan inflammation, and develops diagnostic pathways for liver disease. Collaborations include bariatric surgery services at Homerton Hospital and institutions across Europe and the USA.

Scientific Contributions: Notable awards include the Academy of Medical Sciences Starter Grant and MRC New Investigator Award. His translational research spans epidemiology, clinical trials for NASH therapies, and microbiome studies in liver disease progression.

• Current research: Innate immune pathways in NASH, microbiome profiling, sepsis prediction post-surgery
• Clinical leadership: NAFLD clinical lead at Barts Health, Head of Research for LAP Research charity